Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	3.11	37.95	36.81
Graham Fair Price	23.44	12.04	9.76
PEG	-66.81	0.34	-1.03
Price/Book	-2.76	5.42	5.57
Price/Cash Flow	109.18	-42.74	20.43
Prices/Earnings	-37.63	18.73	30.04
Price/Sales	-3.47	4.94	5.12
Price/FCF	109.18	-42.74	20.43
Naive Interpretation	member

01 - Valuation · Somewhat Positive

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-1.89	0.45	0.45
Operating Margin	2.42	0.11	0.11
ROA	71.48	0.02	< 0.005
ROE	0.05	0.07	55.92
ROIC	0.03	0.03	-3.56
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	< 0.005	-0.03	75.32
Dividends QOQ	-0.05	0.23	373.82
EBIT QOQ	2.02	0.02	-99.17
EPS QOQ	-0.29	0.55	87.88
FCF QOQ	3.12	-1.46	-53.30
Revenue QOQ	0.04	< 0.005	-79.80
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	< 0.005	100.00
Days Sales Outstanding (DSO)	106.30	110.41	3.86
Inventory Turnover	0.00	163523000.00	100.00
Debt/Capitalization	0.67	0.67	0.39
Quick Ratio	1.29	1.15	-11.15
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	9.55	9.45	-1.14
Cash	13.02	4.24	-67.47
Capex	-0.18	-0.17	4.92
Free Cash Flow	2.60	-1.20	-54.04
Revenue	10.39	10.35	-0.42
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.54	1.74	13.33
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	7.76	9.21	18.67
Naive Interpretation	Member

06 - Financial Health · Weak

Rating